Our study here revealed a negative regulatory role of FOXP3 in tuning the self-renewal of cCSCs by inhibiting COX2 expression, which provides a new target and strategy for the removal of colon cancer stem cells. Here, PTGS2 is linked to malignant colon neoplasm.